JPMorgan Chase & Co’s Applied Therapeutics APLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$617 Sell
1,984
-51,923
-96% -$16.1K ﹤0.01% 5785
2025
Q1
$26.4K Buy
53,907
+2,357
+5% +$1.15K ﹤0.01% 5210
2024
Q4
$44.1K Buy
51,550
+3,237
+7% +$2.77K ﹤0.01% 5046
2024
Q3
$411K Buy
48,313
+7,175
+17% +$61K ﹤0.01% 4133
2024
Q2
$192K Sell
41,138
-137,786
-77% -$643K ﹤0.01% 4296
2024
Q1
$1.22M Buy
178,924
+131,991
+281% +$898K ﹤0.01% 3444
2023
Q4
$157K Buy
46,933
+46,545
+11,996% +$156K ﹤0.01% 4566
2023
Q3
$966 Sell
388
-26,715
-99% -$66.5K ﹤0.01% 5691
2023
Q2
$34.7K Sell
27,103
-48,643
-64% -$62.3K ﹤0.01% 4936
2023
Q1
$61K Buy
75,746
+75,358
+19,422% +$60.7K ﹤0.01% 4837
2022
Q4
$0 Sell
388
-1,646
-81% ﹤0.01% 5550
2022
Q3
$2K Buy
2,034
+812
+66% +$798 ﹤0.01% 5311
2022
Q2
$1K Sell
1,222
-10,328
-89% -$8.45K ﹤0.01% 5464
2022
Q1
$25K Buy
11,550
+2,292
+25% +$4.96K ﹤0.01% 5221
2021
Q4
$83K Buy
9,258
+487
+6% +$4.37K ﹤0.01% 4899
2021
Q3
$146K Buy
8,771
+685
+8% +$11.4K ﹤0.01% 4544
2021
Q2
$168K Sell
8,086
-1,434
-15% -$29.8K ﹤0.01% 4566
2021
Q1
$179K Buy
9,520
+3,377
+55% +$63.5K ﹤0.01% 4490
2020
Q4
$135K Buy
6,143
+1,056
+21% +$23.2K ﹤0.01% 4244
2020
Q3
$103K Buy
5,087
+590
+13% +$11.9K ﹤0.01% 4028
2020
Q2
$162K Buy
4,497
+1,868
+71% +$67.3K ﹤0.01% 3760
2020
Q1
$86K Sell
2,629
-5,789
-69% -$189K ﹤0.01% 3986
2019
Q4
$230K Buy
8,418
+7,522
+840% +$206K ﹤0.01% 3755
2019
Q3
$10K Buy
+896
New +$10K ﹤0.01% 4563